Buy Montelukast 10 mg + Levocetirizine 5 mg + Ambroxol 75 mg SR Tablets for Bulk Order
What is Montelukast 10 mg + Levocetirizine 5 mg + Ambroxol 75 mg SR Tablets?
Montelukast 10 mg + Levocetirizine 5 mg + Ambroxol 75 mg SR Tablets is a combination medication classified within the therapeutic area of respiratory drugs. Montelukast is a leukotriene receptor antagonist, Levocetirizine is an antihistamine, and Ambroxol is a mucolytic agent. This formulation is primarily used for managing allergic rhinitis and asthma, providing synergistic effects to alleviate symptoms while ensuring effective mucus clearance.
The regulatory compliance of this product aligns with international standards, making it suitable for various pharmaceutical applications, including formulation development and research contexts.
What Are the Applications of Montelukast 10 mg + Levocetirizine 5 mg + Ambroxol 75 mg SR Tablets?
- Management of allergic rhinitis and asthma symptoms.
- Mucolytic activity to facilitate respiratory function.
- Research applications in pharmacology and respiratory therapy.
- Formulation development for combination therapies.
- Potential use in clinical trials for efficacy studies.
Why Choose Pharmint as Your Montelukast 10 mg + Levocetirizine 5 mg + Ambroxol 75 mg SR Tablets Supplier?
Pharmint offers unparalleled global sourcing capabilities for pharmaceutical ingredients. We provide comprehensive documentation, including Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS), ensuring regulatory compliance at every stage. Our bulk availability and efficient lead times enhance your supply chain, and our dedicated export support provides seamless international transactions.
Storage & Handling Guidelines for Montelukast 10 mg + Levocetirizine 5 mg + Ambroxol 75 mg SR Tablets
Store Montelukast 10 mg + Levocetirizine 5 mg + Ambroxol 75 mg SR Tablets in a cool, dry place, away from direct light and moisture. Recommended storage temperature is between 15°C to 25°C. Ensure packaging is intact and sealed to prevent air exposure. Available in bulk packaging formats suitable for both commercial and research applications.
Regulatory, Documentation & Export Information
This product is not classified as a controlled precursor; however, an end-use declaration may be required for certain jurisdictions. Available documents include COA, MSDS, and Drug Master Files (DMF) if applicable, ensuring compliance with international regulations.
Montelukast 10 mg + Levocetirizine 5 mg + Ambroxol 75 mg SR Tablets FAQs
What is the shelf life of these tablets?
The shelf life of Montelukast 10 mg + Levocetirizine 5 mg + Ambroxol 75 mg SR Tablets is typically 24 months when stored correctly.
Are there any specific handling precautions?
Always handle the tablets with dry hands and avoid exposure to moisture to maintain product integrity.
Can these tablets be used in combination with other medications?
Consult with a healthcare professional for guidance on combining medications, as interactions may occur.
What documentation is provided with bulk orders?
Bulk orders include COA and MSDS to ensure compliance with regulatory standards.
Is this product suitable for research applications?
Yes, this product is suitable for research applications and can be used in pharmacological studies and clinical trials.
Reviews
There are no reviews yet.